Complete Filing Data
BlackRock, Inc. reported Stockholders Equity Including Portion Attributable To Noncontrolling Interest of $56.12 billion for FY2025.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean BlackRock, Inc. did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Net Income * | $5.55B | $6.37B | $5.50B | $5.18B |
| Revenue From Contract With Customer Excluding Assessed Tax | $24.22B | $20.41B | $17.86B | $17.87B |
| Profit Loss Excluding Redeemable Noncontrolling Interests | $5.55B | $6.37B | $5.52B | $5.18B |
| Other Comprehensive Income Loss Net Of Tax | $606.0M | -$338.0M | $261.0M | -$551.0M |
| Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax | $606.0M | -$338.0M | $261.0M | -$551.0M |
| Operating Income Loss | $7.05B | $7.57B | $6.28B | $6.39B |
| Operating Expenses | $17.17B | $12.83B | $11.58B | $11.49B |
| Nonoperating Income Expense | $574.0M | $721.0M | $880.0M | -$95.0M |
| Interest Expense Nonoperating | $614.0M | $538.0M | $292.0M | $212.0M |
| Income Tax Expense Benefit | $1.68B | $1.78B | $1.48B | $1.30B |
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | $7.62B | $8.30B | $7.16B | $6.29B |
| General And Administrative Expense | $2.73B | $2.26B | $2.09B | $2.06B |
| Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest | $6.55B | $6.17B | $5.94B | $4.44B |
| Comprehensive Income Net Of Tax | $6.16B | $6.03B | $5.76B | $4.63B |
| Restructuring Charges | $39.0M | $0.00 | $61.0M | $91.0M |
| Income Loss From Equity Method Investments | $51.0M | $41.0M | $378.0M | $29.0M |
| Deferred Income Tax Expense Benefit | -$631.0M | -$106.0M | $124.0M | $602.0M |
| Amortization And Impairment Of Intangible Assets | $775.0M | $291.0M | $151.0M | $151.0M |
| Net Income Loss Attributable To Noncontrolling Interest | $143.0M | $174.0M | -$184.0M | |
| Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest | $143.0M | $174.0M | -$184.0M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 |
|---|---|---|---|---|---|---|---|---|
| Net Income * | $1.32B | $1.59B | $1.51B | $1.63B | $1.50B | $1.57B | $1.60B | |
| Revenue From Contract With Customer Excluding Assessed Tax | $6.51B | $5.42B | $5.28B | $5.20B | $4.81B | $4.73B | $4.52B | |
| Profit Loss Excluding Redeemable Noncontrolling Interests | $1.33B | $1.59B | $1.51B | $1.62B | $1.50B | $1.57B | $1.61B | |
| Other Comprehensive Income Loss Net Of Tax | -$43.0M | $436.0M | $227.0M | $346.0M | -$45.0M | -$93.0M | -$221.0M | |
| Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax | -$43.0M | $436.0M | $227.0M | $346.0M | -$45.0M | -$93.0M | -$221.0M | |
| Operating Income Loss | $1.96B | $1.73B | $1.70B | $2.01B | $1.80B | $1.69B | $1.64B | |
| Operating Expenses | $4.55B | $3.69B | $3.58B | $3.19B | $3.01B | $3.04B | $2.89B | |
| Nonoperating Income Expense | $42.0M | $521.0M | $65.0M | $259.0M | $214.0M | $220.0M | $171.0M | |
| Interest Expense Nonoperating | $135.0M | $173.0M | $166.0M | $154.0M | $126.0M | $92.0M | $82.0M | |
| Income Tax Expense Benefit | $470.0M | $587.0M | $248.0M | $574.0M | $477.0M | $290.0M | $213.0M | |
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | $2.00B | $2.25B | $1.76B | $2.27B | $2.01B | $1.91B | $1.81B | |
| General And Administrative Expense | $782.0M | $689.0M | $711.0M | $562.0M | $534.0M | $529.0M | $518.0M | |
| Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest | $1.48B | $2.10B | $1.74B | $2.04B | $1.49B | $1.53B | $1.37B | |
| Comprehensive Income Net Of Tax | $1.28B | $2.03B | $1.74B | $1.98B | $1.45B | $1.48B | $1.38B | |
| Restructuring Charges | $0.00 | $39.0M | $0.00 | $0.00 | $61.0M | |||
| Income Loss From Equity Method Investments | $51.0M | $48.0M | ||||||
| Deferred Income Tax Expense Benefit | $15.0M | -$41.0M | ||||||
| Amortization And Impairment Of Intangible Assets | $253.0M | $89.0M | $39.0M | |||||
| Net Income Loss Attributable To Noncontrolling Interest | $72.0M | $5.0M | $60.0M | $42.0M | $50.0M | -$9.0M | ||
| Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest | $72.0M | $5.0M | $60.0M | $42.0M | $50.0M | -$9.0M |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Stockholders Equity * | $55.89B | $47.50B | $39.35B | $37.88B | $37.81B |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $11.49B | $12.78B | $8.75B | $7.43B | $9.34B |
| Gain Loss On Investments | $634.0M | $492.0M | $699.0M | -$35.0M | |
| Dividends Cash | $3.27B | $3.10B | $3.04B | $2.99B | |
| Treasury Stock Value Acquired Cost Method | $1.63B | $1.51B | $1.88B | ||
| Repayments Of Long Term Debt | $796.0M | $1.00B | $0.00 | $750.0M | |
| Operating Lease Right Of Use Asset Amortization Expense | $148.0M | $129.0M | $140.0M | $165.0M | |
| Goodwill | $35.28B | $25.95B | $15.52B | $15.34B | |
| Equity Method Investment Dividends Or Distributions | $429.0M | $57.0M | $49.0M | $50.0M | |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | -$1.29B | $4.03B | $1.32B | -$1.91B | |
| Treasury Stock Value | $1.22B | $386.0M | $11.99B | ||
| Treasury Stock Common Shares | 1.2M | 370.4K | 23.6M | ||
| Separate Accounts Liability | $60.10B | $52.81B | $56.10B |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|
| Stockholders Equity * | $55.52B | $49.14B | $48.04B | $41.18B | $40.27B | $39.90B | $38.78B | $38.35B |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $10.00B | $9.50B | $7.76B | $14.05B | $10.25B | $9.39B | $7.33B | |
| Gain Loss On Investments | $64.0M | $550.0M | $58.0M | $177.0M | $162.0M | $171.0M | $114.0M | |
| Dividends Cash | $810.0M | $808.0M | $838.0M | $757.0M | $758.0M | $795.0M | $748.0M | |
| Treasury Stock Value Acquired Cost Method | $375.0M | $375.0M | $375.0M | $500.0M | $375.0M | $379.0M | ||
| Repayments Of Long Term Debt | $0.00 | $1.00B | ||||||
| Operating Lease Right Of Use Asset Amortization Expense | $34.0M | $32.0M | ||||||
| Goodwill | $35.36B | $28.33B | $28.30B | $15.67B | ||||
| Equity Method Investment Dividends Or Distributions | $14.0M | $8.0M | ||||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | -$5.02B | $638.0M | ||||||
| Treasury Stock Value | $1.16B | $1.29B | $1.04B | $12.83B | ||||
| Treasury Stock Common Shares | 1.2M | 1.3M | 1.0M | 24.1M | ||||
| Separate Accounts Liability | $53.57B | $56.11B | $53.66B | $56.69B |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Adjustments Related To Tax Withholding For Share Based Compensation | $326.0M | $305.0M | $375.0M | $457.0M |
| Share Based Compensation | $1.31B | $753.0M | $630.0M | $708.0M |
| Proceeds From Stock Options Exercised | $167.0M | $464.0M | $95.0M | $11.0M |
| Proceeds From Sale Maturity And Collections Of Investments | $544.0M | $766.0M | $400.0M | $242.0M |
| Proceeds From Repayments Of Borrowings By Consolidated Sponsored Investment Products | -$112.0M | -$58.0M | -$59.0M | -$26.0M |
| Proceeds From Payments To Minority Shareholders | $3.83B | $2.41B | $1.63B | $618.0M |
| Proceeds From Payments For Other Financing Activities | $5.0M | -$18.0M | $26.0M | $27.0M |
| Proceeds From Issuance Of Long Term Debt | $1.08B | $5.47B | $1.24B | $0.00 |
| Proceeds From Equity Method Investment Dividends Or Distributions Return Of Capital | $390.0M | $366.0M | $46.0M | $70.0M |
| Payments To Acquire Property Plant And Equipment | $375.0M | $255.0M | $344.0M | $533.0M |
| Payments To Acquire Investments | $1.38B | $818.0M | $846.0M | $824.0M |
| Payments To Acquire Businesses Net Of Cash Acquired | $3.50B | $2.94B | $189.0M | $0.00 |
| Net Cash Provided By Used In Operating Activities | $3.93B | $4.96B | $4.17B | $4.96B |
| Net Cash Provided By Used In Investing Activities | -$4.42B | -$3.00B | -$959.0M | -$1.13B |
| Net Cash Provided By Used In Financing Activities | -$1.13B | $2.24B | -$1.99B | -$5.44B |
| Increase Decrease In Trading Securities | -$193.0M | -$58.0M | -$72.0M | -$196.0M |
| Increase Decrease In Other Operating Liabilities | $225.0M | -$382.0M | $375.0M | -$481.0M |
| Increase Decrease In Other Operating Assets | $722.0M | -$317.0M | $326.0M | $166.0M |
| Increase Decrease In Non Controlling Interests | -$3.09B | -$2.58B | -$949.0M | -$593.0M |
| Increase Decrease In Employee Related Liabilities | $659.0M | $367.0M | $145.0M | -$711.0M |
| Increase Decrease In Accounts Receivable | $619.0M | $443.0M | $586.0M | -$416.0M |
| Increase Decrease In Accounts Payable And Accrued Liabilities | $75.0M | $259.0M | -$26.0M | -$151.0M |
| Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $329.0M | -$162.0M | $106.0M | -$291.0M |
| Depreciation Amortization And Accretion Net | $1.13B | $529.0M | $427.0M | $418.0M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 |
|---|---|---|---|---|---|---|---|
| Adjustments Related To Tax Withholding For Share Based Compensation | $9.0M | $21.0M | $282.0M | $16.0M | $19.0M | $259.0M | $15.0M |
| Share Based Compensation | $241.0M | $176.0M | |||||
| Proceeds From Stock Options Exercised | $51.0M | $144.0M | |||||
| Proceeds From Sale Maturity And Collections Of Investments | $151.0M | $210.0M | |||||
| Proceeds From Repayments Of Borrowings By Consolidated Sponsored Investment Products | -$24.0M | -$14.0M | |||||
| Proceeds From Payments To Minority Shareholders | $811.0M | $430.0M | |||||
| Proceeds From Payments For Other Financing Activities | -$4.0M | -$15.0M | |||||
| Proceeds From Issuance Of Long Term Debt | $0.00 | $2.98B | |||||
| Proceeds From Equity Method Investment Dividends Or Distributions Return Of Capital | $13.0M | $162.0M | |||||
| Payments To Acquire Property Plant And Equipment | $78.0M | $64.0M | |||||
| Payments To Acquire Investments | $298.0M | $324.0M | |||||
| Payments To Acquire Businesses Net Of Cash Acquired | $3.12B | $0.00 | |||||
| Net Cash Provided By Used In Operating Activities | -$1.13B | -$408.0M | |||||
| Net Cash Provided By Used In Investing Activities | -$3.34B | -$22.0M | |||||
| Net Cash Provided By Used In Financing Activities | -$661.0M | $1.10B | |||||
| Increase Decrease In Trading Securities | -$12.0M | $9.0M | |||||
| Increase Decrease In Other Operating Liabilities | $2.99B | $876.0M | |||||
| Increase Decrease In Other Operating Assets | $3.45B | $796.0M | |||||
| Increase Decrease In Non Controlling Interests | -$522.0M | -$353.0M | |||||
| Increase Decrease In Employee Related Liabilities | -$1.79B | -$1.34B | |||||
| Increase Decrease In Accounts Receivable | -$123.0M | $73.0M | |||||
| Increase Decrease In Accounts Payable And Accrued Liabilities | $84.0M | $196.0M | |||||
| Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $110.0M | -$27.0M | |||||
| Depreciation Amortization And Accretion Net | $194.0M | $111.0M |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Weighted Average Number Of Shares Outstanding Basic | 155.0M | 150.0M | 149.3M | 150.9M |
| Weighted Average Number Of Diluted Shares Outstanding | 160.9M | 151.6M | 150.7M | 152.4M |
| Earnings Per Share Diluted | $35.31 | $42.01 | $36.51 | $33.97 |
| Earnings Per Share Basic | $35.83 | $42.45 | $36.85 | $34.31 |
| Common Stock Dividends Per Share Declared | $20.84 | $20.40 | $20.00 | $19.52 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 |
|---|---|---|---|---|---|---|---|
| Weighted Average Number Of Shares Outstanding Basic | 154.9M | 154.9M | 155.0M | 148.0M | 148.4M | 148.7M | 149.2M |
| Weighted Average Number Of Diluted Shares Outstanding | 165.2M | 156.3M | 156.6M | 149.6M | 149.7M | 150.1M | 150.5M |
| Earnings Per Share Diluted | $8.43 | $10.19 | $9.64 | $10.90 | $9.99 | $10.48 | $10.66 |
| Earnings Per Share Basic | $8.54 | $10.29 | $9.74 | $11.02 | $10.07 | $10.58 | $10.75 |
| Common Stock Dividends Per Share Declared | $5.21 | $5.21 | $5.21 | $5.10 | $5.10 | $5.10 | $5.00 |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Total Sales Asset And Account Expense | $4.46B | $3.78B | $3.50B | $3.51B |
| Subscriptions From Redemptions And Distributions To Noncontrolling Interest Holders | $16.0M | $16.0M | -$16.0M | $4.0M |
| Sub Advisory And Other | $233.0M | $140.0M | $116.0M | $103.0M |
| Stock Issued During Period Value Employee Stock Purchase Plan | $195.0M | $491.0M | $129.0M | $38.0M |
| Sponsor Fees | $2.46B | $2.17B | $2.05B | $2.18B |
| Noncontrolling Interest Consolidation Deconsolidation Of Investment | $44.0M | $0.00 | $21.0M | $9.0M |
| Labor And Related Expense | $8.45B | $6.55B | $5.78B | $5.68B |
| Investment Income Interest And Dividend | $554.0M | $767.0M | $473.0M | $152.0M |
| Direct Fund Expense | $1.77B | $1.46B | $1.33B | $1.23B |
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $1.31B | $753.0M | $630.0M | $708.0M |
| Translation Adjustment For Net Investment Hedge Increase Decrease Net Of Tax | -$96.0M | $37.0M | -$20.0M | $37.0M |
| Net Investment Hedge Tax Expense Benefit | $30.0M | -$12.0M | $6.0M | -$12.0M |
| Other Noncash Income | $289.0M | $126.0M | $0.00 | $268.0M |
| Net Purchases Proceeds Within Consolidated Sponsored Investment Products | -$4.21B | -$2.67B | -$1.78B | -$1.19B |
| Net Gains Losses Realized On Consolidated Sponsored Investment Products | $480.0M | $269.0M | $380.0M | -$400.0M |
| Net Consolidations Deconsolidations Of Sponsored Investment Funds | $97.0M | $127.0M | $26.0M | $85.0M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 |
|---|---|---|---|---|---|---|---|
| Total Sales Asset And Account Expense | $1.16B | $1.06B | $1.01B | $962.0M | $929.0M | $888.0M | $908.0M |
| Subscriptions From Redemptions And Distributions To Noncontrolling Interest Holders | $4.0M | -$4.0M | $2.0M | $12.0M | -$1.0M | $24.0M | -$11.0M |
| Sub Advisory And Other | $60.0M | $46.0M | $47.0M | $34.0M | $32.0M | $32.0M | $28.0M |
| Stock Issued During Period Value Employee Stock Purchase Plan | $62.0M | $54.0M | $58.0M | $91.0M | $25.0M | $151.0M | $32.0M |
| Sponsor Fees | $638.0M | $576.0M | $570.0M | $549.0M | $539.0M | $518.0M | $526.0M |
| Noncontrolling Interest Consolidation Deconsolidation Of Investment | $45.0M | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $19.0M |
| Labor And Related Expense | $2.36B | $1.76B | $1.74B | $1.58B | $1.50B | $1.58B | $1.42B |
| Investment Income Interest And Dividend | $113.0M | $144.0M | $173.0M | $236.0M | $178.0M | $141.0M | $139.0M |
| Direct Fund Expense | $464.0M | $441.0M | $392.0M | $379.0M | $358.0M | $338.0M | $354.0M |
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $419.0M | $226.0M | $241.0M | $156.0M | $179.0M | $176.0M | $146.0M |
| Translation Adjustment For Net Investment Hedge Increase Decrease Net Of Tax | -$62.0M | -$34.0M | -$24.0M | $4.0M | $13.0M | $17.0M | |
| Net Investment Hedge Tax Expense Benefit | $19.0M | $11.0M | $7.0M | -$1.0M | -$4.0M | -$5.0M | |
| Other Noncash Income | $36.0M | $24.0M | |||||
| Net Purchases Proceeds Within Consolidated Sponsored Investment Products | -$1.10B | -$989.0M | |||||
| Net Gains Losses Realized On Consolidated Sponsored Investment Products | $13.0M | $104.0M | |||||
| Net Consolidations Deconsolidations Of Sponsored Investment Funds | $1.0M | $6.0M |
Most recent annual filing with the SEC: February 25, 2026
Data sourced from SEC EDGAR public filings as of August 5, 2026.